NMR studies of the active site of DNA polymerase I and of a 50-residue peptide fragment of the enzyme.

G. P. Mullen,J. B. Vaughn,P. Shenbagamurthi,A. Mildvan

DOI: https://doi.org/10.1016/0006-2952(90)90181-J

IF: 6.1

1990-07-01

Biochemical Pharmacology

Abstract:

What problem does this paper attempt to address?

Variation in sperm precedence during mating in male flies, Dryomyza anilis

M. Otronen

DOI: https://doi.org/10.1006/anbe.1996.0425

IF: 3.041

1997-06-01

Animal Behaviour

Abstract:To understand how individual differences in fertilization success arises in the fly Dryomyza anilisvariation in sperm precedence between and within males was studied. In D. anilisa mating consists of a copulation followed by tapping sequences during which the male taps the external genitalia of the female. These tapping sequences increase last male sperm precedence. Each male in the experiment was repeatedly mated with a set of females. In the first treatment, mating was interrupted after the male had an intromission. In the second treatment, the male was allowed to perform five tapping sequences after an intromission. In the third treatment, the male was allowed to perform an unlimited number of tapping sequences after an intromission until interrupted by female resistance. There were large differences between males in all three treatments as shown by the 95% confidence limits of the mean fertilization success. Repeatabilities of mating time and the number of tapping movements per tapping sequence were high indicating clear differences between males in these components of mating behaviour. Within individual males, the more tappings per sequence, the higher the fertilization success. In matings with an unlimited number of tapping sequences, fertilization success depended on female resistance. Within-male variation in fertilization success was higher in matings with an unlimited number of tapping sequences than in matings interrupted after a copulation. Several components of male mating behaviour thus contribute to the variation in sperm precedence in D. anilisFemale behaviour, in particular, resistance of tapping movements, can also increase variation in sperm precedence.
Treatment of Tear Trough Deformity: Fat Repositioning Versus Autologous Fat Grafting

Chiao-Yun Chiu,Yi-Chen Shen,Qing-Fang Zhao,Fu-Liang Hong,Jing-Hong Xu

DOI: https://doi.org/10.1007/s00266-016-0692-z

IF: 2.708

2016-01-01

Aesthetic Plastic Surgery

Abstract:Fat-preserving lower blepharoplasty techniques and filling techniques using autologous or non-autologous materials are increasingly used to treat tear trough deformity. However, there has been no definitive comparison of the results of fat repositioning versus autologous fat grafting for this condition. The authors used statistical analysis to compare the results of the two methods.
Tear trough rejuvenation using Restylane Eyelight

Munir Somji

DOI: https://doi.org/10.12968/joan.2022.11.9.396

2022-11-12

Journal of Aesthetic Nursing

Abstract:Hyaluronic acid filler injection treatment represents the second most commonly performed non-surgical treatment worldwide behind botulinum toxin injections ( International Society of Aesthetic Plastic Surgery, 2020 ). This should come as no surprise, as dermal filler treatments represent a swift non-surgical technique with immediate and long-lasting results. Consequently, such treatments are gaining global acceptance ( Berguiga and Galatoire, 2017 ). It is known that periocular rejuvenation is one of the chief concerns for patients seeking aesthetic enhancement ( Eyelight, 2020 ). Therefore, it is the author's belief that possessing the expertise to carry out tear trough rejuvenation is an important skill to acquire in one's medical practice. To achieve ideal results, the aesthetic practitioner must have an innate knowledge of anatomy, as well as assessment and treatment techniques of the area. This article will review the evidence relating to hyaluronic acid dermal fillers and the clinical outcomes for patients who require tear trough treatment.
New anticancer drugs under clinical trials in Japan.

M. Ogawa,Y. Ariyoshi

DOI: https://doi.org/10.1016/S0889-8588(18)30173-4

IF: 2.861

1994-04-01

Hematology/Oncology Clinics of North America

Abstract:
Nonsurgical Treatments for Infraorbital Rejuvenation: A Review

Michael Lipp,Eduardo Weiss

DOI: https://doi.org/10.1097/DSS.0000000000001897

Abstract:Background: Tear trough and infraorbital region changes are one of the first signs recognizable aging. This is a common consultation for cosmetic dermatologists and there are many treatment options available. Objective: This article provides a review of the anatomy and changes that occur in the infraorbital region as we age. We also suggest the use of the osseous, color, underlying anatomy, laxity, adipose, rhytides (OCULAR) mnemonic to evaluate these changes and review the literature for treatments options. Materials and methods: A literature search was performed through PubMed, using search terms "Tear trough," "Infra-orbital," "Dark-circles," "Lower-Eyelid," and "Midface." Results: Fillers, lasers, radiofrequency devices, chemical peels, various topicals, and botulinum toxin are available non-surgical treatment options discussed in the literature found to significantly improve and rejuvenate the infraorbital region. Conclusion: A complete understanding of the anatomy and changes that occur with aging are of most importance when assessing the infraorbital region. Organizing these changes into the OCULAR mnemonic is one way to assess the infraorbital region and achieve optimal rejuvenation.
Fat Repositioning Versus Hyaluronic Acid Fillers

Stylianos Christodoulou,Argyrios Tzamalis,Ioannis Tsinopoulos,Nikolaos Ziakas

DOI: https://doi.org/10.3390/jpm14111096

IF: 3.5083

2024-11-07

Journal of Personalized Medicine

Abstract:Objective: This paper compares two popular techniques for tear trough correction—fat repositioning and hyaluronic acid (HA) fillers—highlighting their efficacy, safety profiles, patient satisfaction, and associated complications. Methods: A narrative review of 20 studies comparing fat repositioning and HA fillers was conducted, focusing on parameters such as duration of results, volume restoration, complication rates, and patient satisfaction. Results: Fat repositioning provides long-lasting results but carries higher surgical risks compared with HA fillers. The transconjunctival approach is suitable for patients with minimal skin excess. The supraperiosteal plane allows for a quicker procedure and, despite postoperative edema and temporary irregular contouring, shows no difference in final cosmetic outcomes compared with other planes. Internal fixation reduces the risk of fat relapse and skin scarring but carries the risk of suboptimal positioning. HA fillers offer immediate, minimally invasive results but require periodic maintenance. The use of a cannula reduces the risk of vascular occlusion. Combining a high G' filler for the midface with a low G' with low hydrophilicity for the tear trough reduces the amount of filler needed and prolongs the results. Both surgical and non-surgical methods are effective, depending on patient needs and anatomical considerations. Conclusions: Fat repositioning is ideal for patients seeking long-term correction and are willing to undergo surgery, while HA fillers suit those preferring non-invasive treatments with customizable, short-term effects. Both techniques have pros and cons that must be matched to patient goals and conditions.

medicine, general & internal,health care sciences & services
Surgical Correction of Tear Trough Deformity (TTD) with Orbicularis Retaining Ligament Release and Volume Augmentation for Periorbital Rejuvenation: Review of the Literature

Bishara Atiyeh,Christopher-Roland Hakim,Ahmad Oneisi,Fadi Ghieh,Fadel Chahine

DOI: https://doi.org/10.1007/s00266-022-03183-0

IF: 2.708

2022-12-03

Aesthetic Plastic Surgery

Abstract:Tear trough deformity is a hallmark of periorbital aging. It is not, however, an exclusive feature of old age. While protruding orbital fat results in lower lid bags that are traditionally corrected by excision, correction of TTD can constitute a real challenge requiring volume enhancement in addition to addressing prolapse of orbital fat and descent of cheek tissues. Described therapeutic options include minimally invasive soft tissue augmentation with fillers or structural autologous fat transfer as well as invasive surgical procedures concomitantly with lower lid blepharoplasty or other facial rejuvenation procedures.

surgery
Use of Hyaluronic acid fillers in treatment of periorbital melanosis induced by tear trough deformity: Anatomical considerations, patient satisfaction, and management of complications

Soni Nanda,Shikha Bansal,Ridhima Lakhani

DOI: https://doi.org/10.1111/jocd.14251

Abstract:Background: Periocular melanosis (POM) due to shadow effect of tear trough deformity (TT) does not respond to the conventional treatment modalities. Hyaluronic acid (HA) fillers are a favurable treatment modality. This area is a high risk for injectables due to its unique anatomy. Aims: To find role of HA fillers in treatment POM due to TT deformity with special emphasis on practical anatomy, patient satisfaction rate, and management of complications. A correlation of the grade of TT, age of the patient, and patient satisfaction was done. A follow-up at 1 year was done to assess longevity of results. Methods: Retrospective study of 60 cases of clinically diagnosed POM (120 TT) due to TT deformity was performed. Each patient was injected with 1 ml, cross-linked HA 22.5 mg/ml in under-eye area using 30 G needle or a 25 G cannula. Follow-up was done at 2 weeks, 4 weeks, and 1 year. Results: Mean age of patients was 36.4 years. Majority of patients, that is, 31 (52%) were in the age group of 30-40. As per Hirmand's classification, 46.6% (28/60) had grade 2 TT which was most common. We graded results in the form of VAS and 80% patients had VAS > 7. There were no major side effects. Conclusion: Hyaluronic acid fillers are promising treatment modality without any major side effects. Both needle and cannula can be used effectively. Patient satisfaction is higher in younger patients with low grade of TT and results persisted in all cases for a minimum of 1 year.
Correction of tear trough deformity by hyaluronic acid soft tissue filler placement inferior to the lateral orbital thickening

Uwe Wollina,Alberto Goldman

DOI: https://doi.org/10.1111/dth.15045

Abstract:Tear trough deformities can be a sign of facial aging and exert a negative impact in facial attractiveness. Surgical techniques and adipose tissue transfer have been used to improve tear trough deformity. In recent years, minimal invasive procedures such as soft tissue filler injections became more popular. We report a retrospective evaluation of 45 Caucasian female patients ≥40 years (mean age of [58.8 ± 8.9] years). Severity of tear trough was classified according to Hirmand: 3 as grade I, 28 as grade II, and 14 grade III tear trough deformities. We used a monophasic hyaluronic acid, low G prime filler placed inferior to the lateral orbital thickening. On average, 0.4 ml of hyaluronic acid (HA) filler were injected per side. The improvement was I grade 29 patients and II grades in 16 patients. The improvement lasted (10.8 ± 2.3) months. No severe adverse events were noted. Vascular danger zones can be avoided.
Blepharoplasty Combined with Fat Grafting: A Treatment of Complications Following Polyacrylamide Hydrogel Injections in Tear Troughs

Yang Wang,Yichen Shen,Wei Xiao,Jinghong Xu

DOI: https://doi.org/10.1007/s00266-015-0578-5

IF: 2.708

2015-01-01

Aesthetic Plastic Surgery

Abstract:Background Polyacrylamide hydrogel (PAAG) can cause serious complications during facial augmentation. Previous studies have reported complications following PAAG injections to correct tear troughs.Methods We report a rare case of tear trough deformity following PAAG injections. We developed a comprehensive treatment plan including transcutaneous blepharoplasty and fat grafting to address the presenting complications.Results The patient showed flat lower lids and no more complications 1 year after surgery.Conclusions Blepharoplasty combined with fat grafting is an effective approach to eliminate PAAG injection complications in tear troughs.Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Use of Hyaluronic Acid Filler for Tear-Trough Rejuvenation as an Alternative to Lower Eyelid Surgery

Ana M. S. Morley,Raman Malhotra,Morley, Ana M. S.,Malhotra, Raman

DOI: https://doi.org/10.1097/IOP.0b013e3181b80f93

2019-10-03

Ophthalmic Plastic and Reconstructive Surgery

Abstract:Purpose: To describe one surgeon's experience with the use of hyaluronic acid gel (Perlane) as a tear-trough filler over an 18-month period and to assess patient satisfaction with the procedure. Methods: Consecutive, interventional case series involving case note review, masked grading of clinical photographs, and patient satisfaction survey. Results: A total of 198 eyes of 100 patients were treated, with a mean follow-up of 5.1 months. Patients were principally female (87%), white (89%), and middle-aged (mean age = 47.8 years). Eight percent had previous lower eyelid blepharoplasty, and one had thyroid orbitopathy. The gel was placed preperiosteally, deep to orbicularis, anterior to the inferior orbital rim, with a mean volume of 0.59 ml per eye. The injection procedure was tolerable in 95% of patients without local anesthetic. Side effects described by patients included bruising (75%), swelling (26%), blue discoloration (4%), and lumpiness (33%). However, only 7% required dissolution with hyaluronidase. Eight percent requested additional hyaluronic acid gel within 3 months. Mean downtime was 1 day. Most patients (85%) described marked or moderate satisfaction with the treatment, 5% were ambivalent, and 10% were dissatisfied. Conclusions: This series confirms the effective use of hyaluronic acid gel (Perlane) in tear-trough rejuvenation. It has high patient tolerability, minimal complications, and high patient satisfaction. However, bruising, persistent lumpiness, or lack of perceived effect can lead to dissatisfaction in approximately 10% of cases.

ophthalmology,surgery
Application of infraorbital rim augmentation with pocket fat filling to correct tear trough deformity

Yukun Liu,Yi Wang,Changqi Cai,Xiuying Wu,Haiping Wang

DOI: https://doi.org/10.3389/fsurg.2023.1112402

2023-05-22

Abstract:Background: Tear trough deformity is one of the most common complaints in clinical settings. The correction of this groove is challenging in facial rejuvenation. The lower eyelid blepharoplasty varies with different conditions. A novel approach of using orbital fat in the lower eyelid to increase the volume of the infraorbital rim with granule fat injection has been applied in our institution for more than 5 years. Objectives: This article aims to describe the detailed steps of our technique and verify its effectiveness by a cadaveric head dissection after surgical simulation. Methods: In this study, a total of 172 patients with tear trough deformity underwent lower eyelid orbital rim augmentation with fat filling in the sub-periosteum pocket. According to Barton's grades, 152 patients underwent lower eyelid orbital rim augmentation with orbital fat filling, 12 patients had it combined with autologous granule fat from other body parts, and 8 patients received only transconjunctival fat removal to correct tear trough. Results: The modified Goldberg score system was used to compare preoperative and postoperative photographs. Patients were satisfied with the cosmetic results. Excessive protruding fat was released, and the tear trough groove was flattened by using autologous orbital fat transplantation. The lower eyelid sulcus deformities were well-corrected. To further illustrate the anatomical structure of the lower eyelid area and injection layers, six cadaveric heads were used for surgical simulation and demonstrated the effectiveness of our technique. Conclusions: This study indicated that the infraorbital rim could be increased by transplanting orbital fat to the pocket, which was dissected under the periosteum, and the procedure has been verified as reliable and effective. Evidence-based medicine ebm level: Level II.
Bridging the Gap Rather Than Filling the Entire Valley-Anatomic Insights When Treating the Medial Infraorbital Region

Francesco P Bernardini,Brent Skippen,Raul Cetto,Mariana Calomeni,Sebastian Cotofana,Simone Ugo Urso,Ferdinando Paternostro,Morris E Hartstein

DOI: https://doi.org/10.1111/jocd.16582

2024-09-16

Abstract:Background: The treatment of the medial infraorbital region also termed the tear trough has become increasingly popular by the use of soft tissue fillers in a minimally invasive approach using a cannula. Methods: A total of 246 tear troughs were injected and investigated originating from 123 study participants. The clinical outcome was evaluated 6 months after the treatment by independent observers based on standardized frontal images and the procedure was documented by ultrasound imaging. Results: On average, 0.26 (0.1) cc [range: 0.08-0.32] of soft tissue filler material was injected per tear trough. Tear trough depth was before the treatment rated as 2.12 (0.4), whereas after the treatment it was 1.15 (0.4) (p < 0.001). Hyperpigmentation score was 2.19 (0.4) before the treatment, whereas after the treatment it was 1.31 (0.5) (p < 0.001). Intraorbital fat pseudo-prolapse severity was rated before the treatment 1.88 (0.7), whereas it was rated after the treatment 1.14 (0.3) (p < 0.001). Wrinkle severity of the lower eyelid was rated before the treatment 1.51 (0.6), whereas it was rated after the treatment 1.12 (0.3) (p < 0.001). Conclusion: The results of this retrospectively investigated case series revealed that the conducted injection technique for treating the tear trough for medial infraorbital hollowing with a cannula provided statistically significant clinical improvement with a limited adverse events profile. The technique utilized an injection approach which was perpendicularly oriented to the longitudinal axis of the tear trough thereby "bridging the gap instead of filling the entire valley."
Non-surgical Volume Enhancement with Fillers in the Orbit and Periorbital Tissues: Cosmetic and Functional Considerations

Ana M. Susana Morley,Raman Malhotra

DOI: https://doi.org/10.1007/978-3-540-85542-2_15

2010-01-01

Abstract:Abstract Orbital or periorbital volume loss may be due to factors other than aging. Any sinister, progressive, or reversible etiology should be identified and addressed prior to embarking upon volume replacement. Injectable soft-tissue fillers offer titratable volume augmentation, precise soft-tissue placement, the ability to be performed in the office, biocompati-bility, low down-time, minimal morbidity, high safety and, in most cases, potential reversibility. The two main types of injectable soft-tissue fillers are collagen and stabilized hyaluronic acid. The latter can be instantly dissolved using hyaluroni-dase. Nonanimal stabilized hyaluronic acid fillers are the most commonly used in orbital and periorbital volume augmentation. Fillers with larger particle size have increased viscos-ity reduced ease of injection and increased duration. On average, a medium viscosity hyaluronic acid gel will last a year when injected in a pre-periosteal plane in the periorbital region or in the orbit. Soft-tissue fillers have been successfully used for volume augmentation in the orbit (both sighted and anophthalmic), the tear trough, the upper eyelid/sub-brow region and in the brow and temple region. 2 ml of hyaluronic acid filler, administered to the orbit via an inferotemporal peribulbar injection and placed posterior to the equator of the globe or implant, usually reduces enophthalmos by up to 2 mm and restores the signs of periorbital volume deficiency. A serial-puncture technique, with deep pre-periosteal placement of small aliquots of filler, followed by molding and massage of the gel, is recommended for filling in periorbital region. Typical side effects of periorbital filler injection include bruising and mild swelling, although these usually resolve within a few days and can be concealed with make-up or glasses. Lumpiness can be a problem in a minority of patients but usually settles. Persistent lumpiness can be corrected with further molding, additional filler or, in the case of hyaluronic acid fillers, dissolution with hyaluronidase. Patient satisfaction following periorbital soft- tissue filler for rejuvenation is between 80–95%. The role of injectable soft-tissue fillers in treating periorbital pathology is continuing to expand, with reports of their successful use in treating paralytic lagophthalmos, lower eyelid retraction and cicatricial ectropion.
Correction of tear trough deformity with a cohesive polydensified matrix hyaluronic acid: a case series

Jürgen Huber-Vorländer,Martin Kürten

DOI: https://doi.org/10.2147/ccid.s84117

2015-06-01

Abstract:The tear trough or infraorbital hollow is a challenging area to treat, and only a few fillers are suitable for this delicate area. We report on a European case series of six subjects with mild to severe tear troughs who received treatment with cohesive polydensified matrix (CPM(®)) technology hyaluronic acid gel (Belotero(®) Balance). The product was injected as small depots (up to ten small boli 0.2 mL maximum each per side) at the supraperiosteal level along or below the orbital rim. Follow-up visits took place at 1, 3, 6, and 9 months after injection for independent evaluation of the clinical effect using the Merz Aesthetics Scale™ for infraorbital hollows and the Global Aesthetic Improvement Scale. Adverse events were also recorded. Mean hollowness scores were considerably improved compared with baseline in all subjects. In all women, the improvements remained throughout the 9-month study, with none reverting to their baseline score. Subjects' satisfaction with treatment was very high throughout the study, and all women stated that they would repeat treatment with the same product. The CPM hyaluronic acid gel was well tolerated. CPM hyaluronic acid gel is a safe and effective treatment for the tear trough area.

dermatology
Combination Approach to Tear Trough Deformities and Under Eye Appearance Using Microfocused Ultrasound With Visualization and Hyaluronic Acid Filler

Sheila C. Barbarino

DOI: https://doi.org/10.1177/0748806820947580

2020-08-07

The American Journal of Cosmetic Surgery

Abstract:Filler for tear trough deformities and improved under eye appearance has become a well-accepted procedure to treat fine lines, wrinkles, shadowing, darkness, and hollowness. Microfocused ultrasound with visualization–induced skin tightening can be a powerful modality to treat periocular laxity on its own. There is also considerable rationale for combining these 2 modalities for synergistic rejuvenation of the entire periocular area. This case series recruited participants with mild-to-moderate skin laxity in the periocular area and tear trough deformities. Participants received microfocused ultrasound with visualization therapy followed 3 months later by injection with Cohesive Polydensified Matrix hyaluronic acid gel. Photographs were taken at baseline, 3 months after microfocused ultrasound with visualization therapy, and 1 month after Cohesive Polydensified Matrix hyaluronic acid injection for rating by physicians and participants using the Global Aesthetic Improvement Scale. All participants also completed a satisfaction questionnaire. This pilot study enrolled 10 participants ranging in age from 35 to 55 years. After microfocused ultrasound with visualization alone, physicians rated 4 participants “much improved,” 5 “improved,” and 1 with “no change.” After participants had received both treatment modalities, physicians rated 9 participants as “very much improved” and 1 as “much improved.” Participant satisfaction was high with microfocused ultrasound with visualization alone and even higher with the combined treatment approach with all 10 participants reporting their periocular appearance “very much improved” at the end of the study. No treatment complications were observed. In conclusion, microfocused ultrasound with visualization in combination with Cohesive Polydensified Matrix hyaluronic acid gel was effective at improving appearance of the eye area in participants with periocular skin laxity and tear trough deformities.

English Else
Infraorbital Hollow Rejuvenation: Considerations, Complications, and the Contributions of Midface Volumization

Julie Woodward,Sue Ellen Cox,Kiyoko Kato,Fernando Urdiales-Galvez,Charles Boyd,Nazanin Ashourian

DOI: https://doi.org/10.1093/asjof/ojad016

2023-01-01

Aesthetic Surgery Journal Open Forum

Abstract:Abstract Infraorbital hollows are one of the most common target areas for facial aesthetic treatment; however, they are often perceived to be challenging to treat due to the complex anatomy of the periorbital area, concurrent deformities, and risk of complications. Treatment options include surgical (eg, lower eyelid blepharoplasty with fat transposition or injections) and nonsurgical approaches (eg, fillers). Among these approaches, filler injections have become common practice because they are minimally invasive and provide long-term patient satisfaction. In particular, hyaluronic acid (HA) fillers have been shown to be safe and effective for infraorbital hollow rejuvenation. This review provides an overview of infraorbital hollows, including periorbital anatomy, etiology, clinical assessment, and overlapping deformities, such as malar mounds, festoons, and dark circles under the eyes. Patient and HA filler product selection, injection techniques, as well as potential adverse events, such as bruising/swelling, lower eyelid and malar edema, and vascular occlusions, are discussed. This review also highlights the importance of midfacial volumization to improve outcomes in the infraorbital region and in the overall aesthetic appearance. By selecting appropriate patients and attaining proficiency in periorbital anatomy and infraorbital hollow rejuvenation techniques, clinicians can safely and successfully perform HA filler injections that result in high patient satisfaction. Level of Evidence: 5
Filler‐based correction of tear trough depressions and eye bags in Japanese patients: A classification system and treatment algorithm

Kiyoko Kato,Tomoe Kajiwara,Nobutaka Furuyama,Steven Liew

DOI: https://doi.org/10.1111/jocd.15449

2022-10-10

Journal of Cosmetic Dermatology

Abstract:Background Tear trough depressions are widely treated with fillers. However, it is questionable whether the same strategies can always be used for Caucasian and Japanese patients, owing to differences in bone and skin structures and epithelial thickness. Aims To assess a novel classification system and treatment algorithm for correcting tear trough depressions and eye bags in Japanese patients. Methods Tear trough depressions can be classified into three types according to the presence or absence of a 'negative vector' based on retrusion of the maxilla relative to the anterior corneal surface, with or without eye‐bag protrusion when smiling. Type 1 patients (without the negative vector) can be treated simply by filling the depression in the tear trough and the palpebromalar groove region. Type 2 patients (with a negative vector and no eye‐bag protrusion on smiling) also require volume restoration in the mid‐cheek (deep medial cheek fat, suborbicularis oculi fat, and pre‐maxillary space); this not only enables volume recovery but also compensates for maxillary deficiency. Type 3 patients (with a negative vector and eye‐bag protrusion on smiling) require an additional step, based on placing a filler in front of the eye bags and pushing orbital fat backwards. Results Cases presentations demonstrate the utility of the techniques involved. Conclusions This system provides a simple and practical method for classifying and treating Japanese patients with tear trough depressions and eye bags. Further studies are warranted.

dermatology
Eyelid and Periorbital Dermal Fillers: Products, Techniques, and Outcomes

José Raúl Montes,Elizabeth Santos,Claudia Amaral

DOI: https://doi.org/10.1016/j.fsc.2021.01.003

Abstract:A retrospective observational case study and a literature review were conducted to evaluate how anatomic findings, especially those related to the periorbital zone, serve as a guiding compass for injectable implants. Treatment techniques and product selection will be discussed for patients with negative vector, shallow orbit, and deep set eyes. Versatility of injectables will be demonstrated on patients with peanut face, iatrogenically altered anatomy (after surgery), and trauma.
Delayed Complications following Dermal Filler for Tear Trough Augmentation: A Systematic Review

Lily Nguyen Trinh,Kelly C McGuigan,Amar Gupta

DOI: https://doi.org/10.1055/s-0041-1736390

Abstract:Tear trough deformity is a popular target for the treatment with filler injections. The side effects are generally mild and transient. However, delayed complications may occur. We aim to perform a thorough systematic review of the published literature related to delayed complications after tear trough filler injections. A search of published literature was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines in June 2021 and included PubMed, ScienceDirect, and Embase databases. The Medical Subject Headings (MeSH) terms used included the following terms: delayed complications, nodules, granulomas, swelling, discoloration, dermal filler, hyaluronic acid (HA), polyacrylamide, calcium hydroxyapatite (CaHA), poly-L-lactic acid (PLLA), eyelid, periorbital, periocular, and tear trough. Twenty-eight articles consisting of 52 individual cases were included in the final analysis. 98% (51/52) of patients were female and had an average age of 48.3 years. HA was the most reported product (71.2%, 37/52), followed by PLLA (4/52, 7.7%), and CaHA (4/52, 7.7%). The most common delayed complication with any dermal filler was swelling (42.3%, 22/52) followed by lumps or nodules (25.0%, 13/52). Xanthelasma-like reaction (17.3%, 9/52), migration (7.7%, 4/52), discoloration (3%, 3/52) also occurred. The average time of onset of any complication was 16.8 months with xanthelasma-like reaction appearing soonest (mean: 10 months) and discoloration appearing latest (mean: 52 months). Most swelling cases were caused by HA. Semi-permanent fillers such as PMMA and synthetic fillers such as PLLA were more likely to be associated with lumps and nodules than other complications. It is important that clinicians who perform tear trough augmentation with dermal fillers have a thorough understanding of the risks of the procedure to diagnose and manage them promptly as well as provide patients with accurate information regarding the potential adverse effects.

NMR studies of the active site of DNA polymerase I and of a 50-residue peptide fragment of the enzyme.

Variation in sperm precedence during mating in male flies, Dryomyza anilis

Treatment of Tear Trough Deformity: Fat Repositioning Versus Autologous Fat Grafting

Tear trough rejuvenation using Restylane Eyelight

New anticancer drugs under clinical trials in Japan.

Nonsurgical Treatments for Infraorbital Rejuvenation: A Review

Fat Repositioning Versus Hyaluronic Acid Fillers

Surgical Correction of Tear Trough Deformity (TTD) with Orbicularis Retaining Ligament Release and Volume Augmentation for Periorbital Rejuvenation: Review of the Literature

Use of Hyaluronic acid fillers in treatment of periorbital melanosis induced by tear trough deformity: Anatomical considerations, patient satisfaction, and management of complications

Correction of tear trough deformity by hyaluronic acid soft tissue filler placement inferior to the lateral orbital thickening

Blepharoplasty Combined with Fat Grafting: A Treatment of Complications Following Polyacrylamide Hydrogel Injections in Tear Troughs

Use of Hyaluronic Acid Filler for Tear-Trough Rejuvenation as an Alternative to Lower Eyelid Surgery

Application of infraorbital rim augmentation with pocket fat filling to correct tear trough deformity

Bridging the Gap Rather Than Filling the Entire Valley-Anatomic Insights When Treating the Medial Infraorbital Region

Non-surgical Volume Enhancement with Fillers in the Orbit and Periorbital Tissues: Cosmetic and Functional Considerations

Correction of tear trough deformity with a cohesive polydensified matrix hyaluronic acid: a case series

Combination Approach to Tear Trough Deformities and Under Eye Appearance Using Microfocused Ultrasound With Visualization and Hyaluronic Acid Filler

Infraorbital Hollow Rejuvenation: Considerations, Complications, and the Contributions of Midface Volumization

Filler‐based correction of tear trough depressions and eye bags in Japanese patients: A classification system and treatment algorithm

Eyelid and Periorbital Dermal Fillers: Products, Techniques, and Outcomes

Delayed Complications following Dermal Filler for Tear Trough Augmentation: A Systematic Review